A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin AntibodyShinji Abe, Yasuhiko Nishioka, Masaki Hanibuchi et al.|The Journal of Immunology|2013Cited by 91
Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumabAtsushi Mitsuhashi, Yasuhiko Nishioka, Shoji Sakiyama et al.|Nature Communications|2015Cited by 80
E7080, a Multi–Tyrosine Kinase Inhibitor, Suppresses the Progression of Malignant Pleural Mesothelioma with Different Proangiogenic Cytokine Production ProfilesKenji Ikuta, Saburo Sone, Van The Trung et al.|Clinical Cancer Research|2009Cited by 72
Surfactant Protein A Suppresses Lung Cancer Progression by Regulating the Polarization of Tumor-Associated MacrophagesAtsushi Mitsuhashi, Yasuhiko Nishioka, Hisatsugu Goto et al.|American Journal Of Pathology|2013Cited by 63
Dll4-Fc, an Inhibitor of Dll4-Notch Signaling, Suppresses Liver Metastasis of Small Cell Lung Cancer Cells through the Downregulation of the NF-κB ActivityTakuya Kuramoto, Yasuhiko Nishioka, Hisatsugu Goto et al.|Molecular Cancer Therapeutics|2012Cited by 49